ACE inhibitors are associated with a reduction in all-cause mortality versus angiotensin II receptor blockers in patients with diabetes mellitus
2018 ◽
Vol 135
◽
pp. 88-92
◽
2005 ◽
Vol 46
(6)
◽
pp. 1080-1087
◽
2020 ◽
Vol 76
(17)
◽
pp. 2041
2007 ◽
Vol 9
(2)
◽
pp. 89-93
◽
2010 ◽
Vol 144
(2)
◽
pp. 293-294
◽